Center for Health Care Evaluation |
CHCE Investigators
Paul G. Barnett, Ph.D.
Brief Bio
- Director, VA Health Economics Resource Center
- Health Economist, Center for Health Care
Evaluation and Cooperative Studies Program Coordinating Center
- Consulting Assistant Professor, Department of Health Research and Policy, Stanford University School of Medicine
- BS, University of California, Davis
- Ph.D., University of California,
Berkeley
Research Interests
- Costs and cost-effectiveness of substance abuse treatment
- Evaluating the cost-effectiveness of health care interventions
- Determining the cost of health care in the absence of billing data
Publications
Barnett PG, Masson CL, Sorensen
JL, Wong W, Hall S. Linking opioid dependent hospital patients to
drug treatment: health care use and costs 6 months after randomization. Addiction. 2006;in press.
Chen S, Timko C, Sempel JM, Barnett
PG. Outcomes and costs of matching
the intensity of dual diagnosis treatment to patients'
symptom severity. Journal of Substance Abuse
Treatment. 2006;In press.
Tiet QQ, Byrnes HF, Barnett
PG, Finney JW. A practical system for
monitoring the outcomes of substance use disorder
patients. J Subst Abuse Treat. Jun 2006;30(4):337-347.
Stroupe KT, Morrison DA, Hlatky MA, et al.
Cost-effectiveness of coronary artery bypass grafts versus percutaneous
coronary intervention for revascularization high-risk
patients. Circulation. 2006; in press.
Timko C, Chen S, Sempel JM, Barnett
PG. Dual diagnosis patients in community
or hospital care: one-year outcomes and health care
utilization costs. Journal of Mental Health. 2006; in press.
Weintraub WS, Barnett PG, Chen S, Hartigan P. Economics
methods in the Clinical Outcomes Utilizing Percutaneous Coronary Revascularization
and Aggressive Guideline-Driven Drug Evaluation (COURAGE) trial. American
Heart Journal. 2006;in press.
Sorensen JL, Masson CL, Delucchi K, et al. Randomized
trial of drug abuse treatment-linkage strategies. J Consult Clin
Psychol. Dec 2005;73(6):1026-1035.
Masson CL, Barnett PG, Sees KL, et al. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification. Addiction. Jun 2004;99(6):718-726.
Gould MK, Kuschner WG, Rydzak CE, et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann
Intern Med. Dec 2 2003;139(11):879-892.
Chen S, Smith MW, Wagner TH, Barnett
PG. Spending for specialized mental health treatment in The VA: 1995-2001. Health
Aff (Millwood). Nov-Dec 2003;22(6):256-263.
Berger M, Gould MK, Barnett PG. The cost of positron emission tomography in six United States Veterans Affairs hospitals and two academic medical centers. AJR
Am J Roentgenol. Aug 2003;181(2):359-365.
Gould MK, Sanders GD, Barnett PG, et al. Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. Ann
Intern Med. May 6 2003;138(9):724-735.
Barnett PG, Wagner TH. Preface to the supplement: Frontiers in VA cost determination. Medical
Care Research and Review. 2003;60(3/Supplement):7S-14S.
Barnett PG. Determination of VA health care costs. Med
Care Res Rev. Sep 2003;60(3 Suppl):124S-141S.
Barnett PG, Chen S, Boden WE, et al. Cost-effectiveness
of a conservative, ischemia-guided management strategy after non-Q-wave myocardial
infarction: results of a randomized trial. Circulation. Feb 12 2002;105(6):680-684.
Contact Information
|
|
| Reviewed/Updated Date:
September 03, 2008 |
|